Enhanced wound healing using topical recombinant human platelet-derived growth factor

Nurse Practitioner

Volumn 25, Issue 10, 2000, Pages 85-89

  Stegbauer, Cheryl Cummings ^a  

^a Grossmont Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB;

ARTICLE; BLOOD VESSEL TRANSPLANTATION; CASE REPORT; CHRONIC DISEASE; DRUG EFFECT; FEMALE; HUMAN; LEG ULCER; MIDDLE AGED; NURSING ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; REPERFUSION; WOUND HEALING;

ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHRONIC DISEASE; FEMALE; HUMANS; LEG ULCER; MIDDLE AGED; NURSING ASSESSMENT; PATIENT CARE PLANNING; PLATELET-DERIVED GROWTH FACTOR; REPERFUSION; WOUND HEALING;

EID: 84921431454     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-200025100-00009     Document Type: Article

References (18)

1. Silhi N: Diabetes and wound healing. J Wour.d Care 1998;7:47-51.
2. McGuckin M, Stineman MG, Goin IE, et al.: Venous leg ulcer guideline. Philadelphia, Pa.: University of Pennsylvania, 1997:10.
3. Kane DP, Krasner, D: Wound healing and wound management. In: Chronic wound care: A clinical source book for healthcare professionals, 2nd edition. Wayne, Pa.: Health Management Publications, 1997: l-4.
4. Laing P: The development and complications of diabetic foot ulcers. Am J Surg 1998;176(suppl 2A):11S-19S.
5. Lopez AP, Phillips TJ: Venous ulcers. Wounds 1998:10(5):149-157.
6. Holloway GA: Arterial ulcers: Assessment and viiagnosis. Ostomy Wound Manage 1996;42:46-51.
7. StadeJmann WK, Digenis AG, Tobin GR: Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176(suppl 2A):26S-38S.
8. Cooper DM: The physiology of wound healing: An overview. In: Chronic wound care: A clinical source book for healthcare professionals, 1st edition. King of Prussia, Pa.: Health Management Publications, 1990:1-11.
9. Mast BA, Schultz GS: Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regeneration 1996;4:411-420.
10. Greenhalgh DG: The role of growth factors in wound healing. J Trauma Injury Infection and Critical Care 1996;41:159-167.
11. Bennett NT: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
12. Doughty, D: Principles of wound healing and wound management. In: Acute and chronic wounds: Nursing Management. St. Louis, Mo.: Mosby, 1992;31-68.
13. Beer HD, Longaker MT, Werner S: Reduced expression of PDGF and PDGF receptors during impaired wound healing. Invest Dermatol 1997;109:132-138.
14. Doxey DL, Ng MC, Dill RE, et al.: Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995;57:1111-1123.
15. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vase Surg 1995;21:71-81.
16. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 1998;21:822-827.
17. Rees R, Robson MC, Smiell, JM, et al.: Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study. Wound Repair Regeneration 1997;141-147.
18. Food and Drug Administration: Food and Drug Administration policies on off-label use. http://www.fda.gov.